Targeting the JAK2V617F Hematopoietic Stem Cell Through Integrins-Based Combination Therapy03/01/2023 - 03/01/2025 (PI)
MPN Research Foundation
The bone marrow extracellular matrix: scaffold of hematopoiesis02/01/2019 - 01/31/2025 (PI)
NIH/Office of the Director3K01OD025290-05S1
Targeting JAK2V617F stem cells in primary myelofibrosis12/15/2022 - 11/30/2024 (PI)
NIH/Office of the Director5R03OD031959-02
Targeting the JAK2V617F Hematopoietic Stem Cell through Integrins-Based Combination Therapy03/01/2023 - 02/28/2025 (PI)
MPN Research Foundation and the Leukemia & Lymphoma Society
Role of JAK2 in cerebrovascular and microglial dysfunction in Alzhemeir’s disease02/01/2023 - 01/31/2024 (Co-PI)
Boston University Chobanian and Avedisian School of Medicine
Exploring Integrin-targeting biologics for primary myelofibrosis07/01/2022 - 06/30/2023 (PI)
BU CTSIUL1 TR001430
Mechanistically Interrogate at the Gene Expression Level the effect of Anti-b1 Integrin Antibody on JAK2V617F+ Stem Cells05/01/2022 - 12/31/2022 (PI)
BU CAMED Genome Science Institute